University of Florida researchers have developed a system designed to identify patients at high risk of discontinuing buprenorphine treatment for opioid use disorder. An FDA-approved prescription drug, buprenorphine is one of three commercially available treatments for opioid use disorder proven to be effective in treating both pain and addiction. In a study published in the journal Computers in Biology and Medicine, Md Mahmudul Hasan, Ph.D., and his research team found that roughly 15% of patients did not complete the clinically recommended yearlong buprenorphine treatment, while about 46% of patients stopped Read More
HEALTH DAILY NEWS
Health News, Medical News, Medical conditions, Medical Tests & Procedures, Symptoms, Medical Diagnosis , Health Information, FDA alerts, Drug Watch, Product Watch, Medicine Articles, Welfare, Living